BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 19489875)

  • 21. Cln3-mutations underlying juvenile neuronal ceroid lipofuscinosis cause significantly reduced levels of Palmitoyl-protein thioesterases-1 (Ppt1)-protein and Ppt1-enzyme activity in the lysosome.
    Appu AP; Bagh MB; Sadhukhan T; Mondal A; Casey S; Mukherjee AB
    J Inherit Metab Dis; 2019 Sep; 42(5):944-954. PubMed ID: 31025705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene symbol: CLN3. Disease: Juvenile neuronal ceroid lipofuscinosis (Batten disease).
    Leman AR; Pearce DA; Rothberg PG
    Hum Genet; 2005 May; 116(6):544. PubMed ID: 15991331
    [No Abstract]   [Full Text] [Related]  

  • 23. Loss of CLN3, the gene mutated in juvenile neuronal ceroid lipofuscinosis, leads to metabolic impairment and autophagy induction in retinal pigment epithelium.
    Zhong Y; Mohan K; Liu J; Al-Attar A; Lin P; Flight RM; Sun Q; Warmoes MO; Deshpande RR; Liu H; Jung KS; Mitov MI; Lin N; Butterfield DA; Lu S; Liu J; Moseley HNB; Fan TWM; Kleinman ME; Wang QJ
    Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165883. PubMed ID: 32592935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deletion of the Caenorhabditis elegans homologues of the CLN3 gene, involved in human juvenile neuronal ceroid lipofuscinosis, causes a mild progeric phenotype.
    de Voer G; van der Bent P; Rodrigues AJ; van Ommen GJ; Peters DJ; Taschner PE
    J Inherit Metab Dis; 2005; 28(6):1065-80. PubMed ID: 16435200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Late onset juvenile neuronal ceroid-lipofuscinosis with granular osmiophilic deposits (GROD).
    Hofman IL; Taschner PE
    Am J Med Genet; 1995 Jun; 57(2):165-7. PubMed ID: 7668323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Strategy for mutation detection in CLN3: characterisation of two Finnish mutations.
    Munroe PB; O'Rawe AM; Mitchison HM; Järvelä IE; Santavuori P; Lerner TJ; Taschner PE; Gardiner RM; Mole SE
    Neuropediatrics; 1997 Feb; 28(1):15-7. PubMed ID: 9151312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Self-Complementary AAV9 Gene Delivery Partially Corrects Pathology Associated with Juvenile Neuronal Ceroid Lipofuscinosis (CLN3).
    Bosch ME; Aldrich A; Fallet R; Odvody J; Burkovetskaya M; Schuberth K; Fitzgerald JA; Foust KD; Kielian T
    J Neurosci; 2016 Sep; 36(37):9669-82. PubMed ID: 27629717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The neuronal ceroid lipofuscinoses in human EPMR and mnd mutant mice are associated with mutations in CLN8.
    Ranta S; Zhang Y; Ross B; Lonka L; Takkunen E; Messer A; Sharp J; Wheeler R; Kusumi K; Mole S; Liu W; Soares MB; Bonaldo MF; Hirvasniemi A; de la Chapelle A; Gilliam TC; Lehesjoki AE
    Nat Genet; 1999 Oct; 23(2):233-6. PubMed ID: 10508524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synapse alterations precede neuronal damage and storage pathology in a human cerebral organoid model of CLN3-juvenile neuronal ceroid lipofuscinosis.
    Gomez-Giro G; Arias-Fuenzalida J; Jarazo J; Zeuschner D; Ali M; Possemis N; Bolognin S; Halder R; Jäger C; Kuper WFE; van Hasselt PM; Zaehres H; Del Sol A; van der Putten H; Schöler HR; Schwamborn JC
    Acta Neuropathol Commun; 2019 Dec; 7(1):222. PubMed ID: 31888773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A knock-in reporter mouse model for Batten disease reveals predominant expression of Cln3 in visual, limbic and subcortical motor structures.
    Ding SL; Tecedor L; Stein CS; Davidson BL
    Neurobiol Dis; 2011 Feb; 41(2):237-48. PubMed ID: 20875858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered arginine metabolism in the central nervous system (CNS) of the Cln3-/- mouse model of juvenile Batten disease.
    Chan CH; Ramirez-Montealegre D; Pearce DA
    Neuropathol Appl Neurobiol; 2009 Apr; 35(2):189-207. PubMed ID: 19284480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of chromosome 16 markers in the differential diagnosis of neuronal ceroid-lipofuscinosis.
    Taschner PE; de Vos N; Catsman-Berrevoets CE; van Duinen SG; Lindhout D; Breuning MH
    Am J Med Genet; 1995 Jun; 57(2):338-43. PubMed ID: 7668359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A mouse gene knockout model for juvenile ceroid-lipofuscinosis (Batten disease).
    Katz ML; Shibuya H; Liu PC; Kaur S; Gao CL; Johnson GS
    J Neurosci Res; 1999 Aug; 57(4):551-6. PubMed ID: 10440905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Moving towards therapies for juvenile Batten disease?
    Cooper JD
    Exp Neurol; 2008 Jun; 211(2):329-31. PubMed ID: 18400221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carrier detection of Batten disease (juvenile neuronal ceroid-lipofuscinosis).
    Taschner PE; de Vos N; Post JG; Meijers-Heijboer EJ; Hofman I; Loonen MC; Pinckers AJ; Bleeker-Wagemakers EM; Gardiner RM; Breuning MH
    Am J Med Genet; 1995 Jun; 57(2):333-7. PubMed ID: 7668358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coding sequence and exon/intron organization of the canine CLN3 (Batten disease) gene and its exclusion as the locus for ceroid-lipofuscinosis in English setter dogs.
    Shibuya H; Liu PC; Katz ML; Siakotos AN; Nonneman DJ; Johnson GS
    J Neurosci Res; 1998 May; 52(3):268-75. PubMed ID: 9590435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel homozygous CLN3 missense variant in isolated retinal dystrophy: A case report and electron microscopic findings.
    Mizobuchi K; Hayashi T; Yoshitake K; Fujinami K; Tachibana T; Tsunoda K; Iwata T; Nakano T
    Mol Genet Genomic Med; 2020 Aug; 8(8):e1308. PubMed ID: 32441891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Late infantile neuronal ceroid lipofuscinosis: a new mutation in Arabs.
    Goldberg-Stern H; Halevi A; Marom D; Straussberg R; Mimouni-Bloch A
    Pediatr Neurol; 2009 Oct; 41(4):297-300. PubMed ID: 19748052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of eight novel palmitoyl protein thioesterase (PPT) mutations underlying infantile neuronal ceroid lipofuscinosis (INCL;CLN1).
    Salonen T; Järvelä I; Peltonen L; Jalanko A
    Hum Mutat; 2000; 15(3):273-9. PubMed ID: 10679943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A murine model for juvenile NCL: gene targeting of mouse Cln3.
    Greene ND; Bernard DL; Taschner PE; Lake BD; de Vos N; Breuning MH; Gardiner RM; Mole SE; Nussbaum RL; Mitchison HM
    Mol Genet Metab; 1999 Apr; 66(4):309-13. PubMed ID: 10191119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.